- Home
- BWMX vs XNCR Comparison
BWMX vs XNCR Comparison
Compare BWMX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMX
- XNCR
- Stock Information
- Founded
- BWMX 1995
- XNCR 1997
- Country
- BWMX Mexico
- XNCR United States
- Employees
- BWMX N/A
- XNCR N/A
- Industry
- BWMX Catalog/Specialty Distribution
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- BWMX Consumer Discretionary
- XNCR Health Care
- Exchange
- BWMX Nasdaq
- XNCR Nasdaq
- Market Cap
- BWMX 495.6M
- XNCR 547.8M
- IPO Year
- BWMX N/A
- XNCR 2013
- Fundamental
- Price
- BWMX $13.42
- XNCR $8.60
- Analyst Decision
- BWMX Strong Buy
- XNCR Buy
- Analyst Count
- BWMX 2
- XNCR 10
- Target Price
- BWMX $22.50
- XNCR $23.33
- AVG Volume (30 Days)
- BWMX 39.8K
- XNCR 734.4K
- Earning Date
- BWMX 10-23-2025
- XNCR 11-05-2025
- Dividend Yield
- BWMX 10.81%
- XNCR N/A
- EPS Growth
- BWMX N/A
- XNCR N/A
- EPS
- BWMX 0.84
- XNCR N/A
- Revenue
- BWMX $751,432,052.00
- XNCR $146,929,000.00
- Revenue This Year
- BWMX $6.54
- XNCR $22.06
- Revenue Next Year
- BWMX $6.09
- XNCR N/A
- P/E Ratio
- BWMX $15.91
- XNCR N/A
- Revenue Growth
- BWMX 4.83
- XNCR N/A
- 52 Week Low
- BWMX $7.00
- XNCR $6.92
- 52 Week High
- BWMX $14.46
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- BWMX 58.67
- XNCR 57.89
- Support Level
- BWMX $13.36
- XNCR $8.25
- Resistance Level
- BWMX $13.85
- XNCR $8.73
- Average True Range (ATR)
- BWMX 0.30
- XNCR 0.38
- MACD
- BWMX -0.10
- XNCR 0.07
- Stochastic Oscillator
- BWMX 45.29
- XNCR 78.76
About BWMX Betterware de Mexico S.A.P.I. de C.V.
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.